Drug Safety Service improves ADR reporting in paediatric records

  • PDF / 170,327 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 14 Downloads / 163 Views

DOWNLOAD

REPORT


1

Drug Safety Service improves ADR reporting in paediatric records A pharmacovigilance service appears to improve the documentation of adverse drug reactions (ADRs) within electronic medical records (EMRs) of paediatric patients, according to findings of a retrospective study published in the Journal of Clinical Pharmacology. Data from the Children’s Mercy Hospital system, Kansas City, Missouri, USA, which includes a paediatric hospital, a regional hospital campus and four urgent care centres, were used to investigate the documentation of ADRs within EMRs within 24h after admission to a hospital or clinic from October 2010 (when a Drug Safety Service [DSS] was introduced) until November 2018 in centres with and without quarterly DSS reports to a Pharmacy and Therapeutics committee. Overall, 31% of the 3065 ADRs requiring medical care did not have appropriate ADR documentation in EMRs prior to discharge from the hospital or clinic. ADRs were more frequently documented in EMRs in centres with versus without DSS monitoring (87% vs 61%; p